Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
36.99
63.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Amphastar Pharmaceuticals Inc
Wall Street
Price Targets
AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AMPH
is 59.84 USD
with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
AMPH Last Price Targets
Amphastar Pharmaceuticals Inc
The latest public price target was made on Aug 8, 2024 by
David Amsellem
from
Piper Sandler
,
who expects
AMPH
stock to
rise by 45%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Amsellem
Piper Sandler
|
66
USD
Upside 45% |
3 months ago
Aug 8, 2024
|
Amphastar Pharmaceuticals (AMPH) PT Lowered to $66 at Piper Sandler
StreetInsider
|
|
David Amsellem
Piper Sandler
|
71
USD
Upside 56% |
6 months ago
May 23, 2024
|
Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMPH's stock price target?
Price Target
59.84
USD
According to Wall Street analysts, the average 1-year price target for
AMPH
is 59.84 USD
with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
What is Amphastar Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Amphastar Pharmaceuticals Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
12%.
What is Amphastar Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
17%
The
compound annual growth rate
of Amphastar Pharmaceuticals Inc's operating income for the next 3 years is
17%.
What is Amphastar Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
21%
The
compound annual growth rate
of Amphastar Pharmaceuticals Inc's net income for the next 3 years is
21%.
You don't have any saved screeners yet
